AMANDA TURNER: Open Payments
NPI 1093228769 · GRESHAM, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,429 in 60 payments from 13 companies in 2025. Trend: 2023 $1,637 · 2024 $1,838 · 2025 $1,429
Food & beverage: $1,330Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $349 |
| UCB, Inc. | 14 | $284 |
| Galderma Laboratories, L.P. | 9 | $272 |
| ABBVIE INC. | 11 | $210 |
| MIMEDX Group, Inc. | 3 | $50 |
| LEO Pharma Inc. | 2 | $46 |
| Novartis Pharmaceuticals Corporation | 2 | $40 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $39 |
| Regeneron Healthcare Solutions, Inc. | 1 | $34 |
| BioWound Solutions, Inc. | 2 | $33 |
Products named: TREMFYA, Bimzelx, NEMLUVIO, SKYRIZI, DUPIXENT, bio-ConneKt, GOMEKLI, RINVOQ.
Industry payments across OR — which companies pay providers there.
